![](/img/cover-not-exists.png)
Final Results from Phase II Trial of Neoadjuvant Docetaxel and Capecitabine Given Sequentially or Concurrently for HER2-Negative Breast Cancers
Zelnak, Amelia B., Styblo, Toncred M., Rizzo, Monica, Gabram, Sheryl G., Wood, William C., Harichand-Herdt, Seema, Kim, Sungjin, Liu, Yuan, O'Regan, Ruth M.Volume:
13
Language:
english
Journal:
Clinical Breast Cancer
DOI:
10.1016/j.clbc.2012.12.004
Date:
June, 2013
File:
PDF, 283 KB
english, 2013